With the recent marriage between technology and science aimed at innovating aspects of clinical trials panels composed of experts from fields outside of pharma could prove to be impactful.(outsourcing-pharma.com)
Survey reveals patient perspective on clinical trials
www.appliedclinicaltrialsonline.com
A recent survey of 4,000 patients and care providers examined the patient perspective on clinical trials. The most important motivator to take part in a trial was safety- the clinical trial should do no harm. Institutional support from one’s physician was also important, as were health benefits– the potential to benefit their personal health. (Applied Clinical Trials)
Intercept Pharma’s experimental med could be the first “NASH” treatment
Intercept Pharmaceuticals’ reported that their experimental medicine to treat nonalcoholic steatohepatitis (NASH) achieved its primary goal in a Phase 3 trial, giving it a shot at becoming the first drug to treat the condition. NASH is a chronic disease in which fat accumulates in the liver; patients in the advanced stages of NASH present with cirrhosis and may require a liver transplant in order to survive. (STAT)
Clinical trials a theme at J.P. Morgan Healthcare Conference
The annual J.P. Morgan Healthcare Conference, a health care investment symposium, was held January 7-10, 2019 in San Francisco, with over 9,000 attendees. Numerous sessions discussed inefficiencies in clinical trials and how we can innovate to facilitate research and drug development without placing an undue burden on patients by trial participation requirements. (Healio Gastroenterology)
Join us at the Clinical Trials Congress in San Diego March 3-5
Do you want to meet with senior executives from big pharma, emerging biotech, academia, CROs, technology innovators, regulators, patient groups and hospitals? Network with 700+ attendees and learn how to streamline your clinical trials? The Clinical Trials Congress is part of the Festival of Biologics USA which includes 4 co-located Read more
Boehringer, IBM to test blockchain technology in clinical trials
Boeringer Ingelheim Ltd and IBM Canada plan to explore the use of blockchain technology in clinical trials. This marks the first time that blockchain technology will be used in a clinical trial setting in Canada. The alliance aims to improve the quality of clinical trial processes and record keeping. (Contract Pharma)
Randomized clinical trials with run-in periods: a threat to validity?
Run-in periods are occasionally used in randomized clinical trials to exclude patients after inclusion, but before randomization. During a run-in period, all patients receive the same treatment– for example, a placebo, the experimental drug, or observation only. A recent analysis of published trials found that 5% reported a run-in period, which could affect study validity if a large number of patients are excluded. (Dovepress)
Are remote clinical trials cheaper?
We shouldn’t think of remote clinical trials as something that will decrease costs in and of themselves, simply because remote clinical trials should cost less. One of the biggest driver of cost savings when conducting remote clinical trials is the reduction in the number of investigator sites. Investment in developing a technology platform will be one of the biggest costs. (Clinical Leader)
13 famous clinical trial failures of 2018
Most drug trials fail, and failure is expensive. This is a list of 13 failed clinical trials of drug candidates in 2018 that also touched off a variety of consequences that included termination of development programs, losses in the millions, layoffs, and more. Five of the 13 failed drug candidates were for Alzheimer’s treatments. (Genetic Engineering & Biotechnology News)
TrialAssure discounts trial disclosure software for universities
www.clinicalinformaticsnews.com
Only 11% of universities post clinical trial results to the European Clinical Trial Register (EUCTR) within required timeframes. TrialAssure is offering a program called TrialAssure Academic Pricing (TAP) to assist universities globally through managing and disclosing their clinical trial results in a cost-efficient manner, thus avoiding penalties for non-compliance. (CLINICAL RESEARCH NEWS)
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 9
- Next Page »